Ergomed Plc

Ergomed (ERGO)

Buy
Sell
Company name:Ergomed Plc
EPIC:ERGOTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BN7ZCY67
Market Segment:ASQ1Share Type:DE
WWW Address:http://ergomedgroup.com/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 222.00 uk.advfn.com/p.php?gfx=/gb/down -4.0 [-1.77] 220.00 224.00 226.00 226.00 222.00 45,202
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 102.48 46.16 0.05 -20.00 - - - 250.00 - 142.50

Ergomed Key Figures

(at previous day's close)
Market Cap.102.48m
Shares In Issue46.16m
Prev. Close226.00
PE Ratio- 
Dividend Yield-%
EPS - basic-20.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS2.26p
Return On Equity (ROE)-31.66%
Operating Margin-19.90%
PEG Factor- 
EPS Growth Rate-81.82%
Dividends PS Growth Rate-%
Net Debt13.31m
Gross Gearing39.48%
Quick Assets26.06m
Net Working Capital8.87m
Intangibles / Fixed Assets83.62%
Turnover PS117.22p
Pre-Tax Profit PS-23.33p
Retained Profit PS-19.45p
Cash PS11.24p
Net Cash PS-25.99p
Net Tangible Asset Value PS *23.75p
Net Asset Value PS61.44p
Spread4.00 (1.79%) 

Ergomed Balance Sheet

LSE:ERGO:Liabilities+EQLSE:ERGO:Assets

Share Price Performance

Sample Period HighLow
1 week235.00203.00
4 weeks235.00185.00
12 weeks235.00165.00
1 year250.00142.50

Share Price Chart (5 years)

Ergomed Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week203.0019.009.36203.000.09231.91
4 weeks187.5034.5018.40185.000.27204.78
12 weeks182.5039.5021.64165.000.12198.68
26 weeks149.0073.0048.99142.500.10185.70
1 year228.00-6.00-2.63142.500.09180.05
3 years134.0088.0065.67118.000.07185.53
5 years161.0061.0037.89118.000.06183.21

Ergomed Key Management Ratios

Ergomed Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio142.22 
PE Ratio- 
Tobin's Q Ratio 1.88 
Tobin's Q Ratio (excl. intangibles)3.67 
Dividend Yield-%
Market-to-Book Ratio3.61 
Price-to-Pre-Tax Profit PS-9.52 
Price-to-Retained Profit PS-11.41 
Price-to-Cash Flow PS98.16 
Price-to-Sales PS1.89 
Price-to-Net Tangible Asset Value PS9.35 
Price-to-Cash PS19.75 
Net Working Capital PS19.21 
Price Pct to Working Capital PS11.55%
Earnings Yield-%
Average PE70.75 
Years in average3 
PE to PE average-%

Ergomed Financial Ratios

(Leverage Ratios)
Debt Ratio4.43%
Debt-to-Equity Ratio0.05 
Debt-to-Equity Ratio (excl. Intgbl)0.12 
Debt-to-Equity Market Value0.01 
Net Gearing28.41%
Net Gearing (excl. Intangibles)45.18%
Gross Gearing39.48%
Gross Gearing (excl. Intangibles)62.79%
Gearing Under 1 Year36.67%
Gearing Under 1 Year (excl. Intgbl)58.33%
Assets/Equity1.65 
Cash/Equity18.29 
(Liquidity Ratios)
Net Working Capital to Total Assets18.92%
Current Ratio1.52 
Quick Ratio (Acid Test)1.52 
Liquidity Ratio0.30 
Cash & Equiv/Current Assets19.91%
(Solvency Ratios)
Enterprise Value98.60m
CFO/Sales0.02 
CFO/Attributable Profit- 
CFO/Assets0.02 
CFO/Debt0.06 
Total Debt/Equity Market Value0.18 
Total Debt/Sales0.34 
Total Debt/Pre-Tax Profit-1.72 
Total Debt18.50m
Total Debt/Net Current Assets2.09%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)
0.05270.1120

Ergomed Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-36.28%
Return On Assets (ROA)-16.51%
Net Profit Margin-16.60%
Assets Turnover0.99 
Return On Equity (ROE)-31.66%
Return On Investment (ROI)-23.11%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-16.60%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.71 
Fixed Assets Turnover1.86 
Current Assets Turnover2.14 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales1.01 
Debtors-to-Sales38.56%
Debt Collection Period140.74Days

Ergomed Dividends

Sorry No Data Available

Ergomed Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover30.18100.00%39.23100.00%47.62100.00%54.11100.00%m
pre tax profit2.076.87%0.330.83%-4.45-9.34%-10.77-19.90%m
attributable profit1.555.14%0.481.22%-4.50-9.46%-8.98-16.60%m
retained profit1.555.14%0.481.22%-4.50-9.46%-8.98-16.60%m
eps - basic (p)5.40 1.30 -11.00 -20.00 
eps - diluted (p)5.20 1.30 -11.00 -20.00 
dividends per share- - - - 

Ergomed Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
LSE:ERGO:Liabilities+EQLSE:ERGO:AssetsLSE:ERGO:Liabilities+EQLSE:ERGO:AssetsLSE:ERGO:Liabilities+EQLSE:ERGO:AssetsLSE:ERGO:Liabilities+EQLSE:ERGO:Assets
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets0.341.36%0.721.32%1.081.74%1.342.87%m
intangibles intangibles10.3141.74%32.1359.06%35.5057.34%17.4037.13%m
fixed investments fixed investments0.180.74%0.270.50%0.751.22%2.074.41%m
current assets - other current assets - other--%--%0.500.81%--%m
stocks stocks--%0.450.83%--%--%m
debtors debtors9.8940.07%16.4130.16%20.8633.70%20.8744.53%m
cash & securities cash & securities3.9716.09%4.428.13%3.225.20%5.1911.07%m
TOTAL24.69100%54.40100%61.91100%46.86100%m
LIABILITIES
creditors - short creditors - short7.2329.29%8.5915.80%13.8622.39%17.1936.67%m
creditors - long creditors - long0.522.12%11.2020.58%13.2121.33%1.312.80%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL7.7631.41%19.7936.38%27.0743.72%18.5039.48%m
EQUITY
ord cap, reserves ord cap, reserves16.9468.59%34.6163.62%34.8456.28%28.3660.52%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL16.9468.59%34.6163.62%34.8456.28%28.3660.52%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Ergomed Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF0.26-2.370.031.04m
Pre-Financing CF-0.60-8.21-3.89-1.69m
Retained CF-0.600.45-1.212.08m

Ergomed Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
ERGO
Ergomed
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190522 22:41:44